Home > Resources > Whitepapers > NEW PERSPECTIVES ON THE FUTURE OF DRUG DISCOVERY

NEW PERSPECTIVES ON THE FUTURE OF DRUG DISCOVERY

This white paper employs a case study of three biotechnology and three pharmaceutical companies to demonstrate how those techniques can be applied to examining large data sets to measure large and small molecule drug pipeline trends. Nerac’s information analysis was applied to non-patent and patent data to reach conclusions about drug development trends.

Spotlight

SE Healthcare

The SE Healthcare team has been at the forefront of enhancing safety and quality in healthcare for over 10 years. Our mission is to empower healthcare providers through the Physician Empowerment™ Suite, a set of specialty-specific data analytics platforms created to increase quality of care, reduce risk, improve reputation, and enhance reimbursements to enrich financial health.

OTHER WHITEPAPERS

Leveraging innovations in plasmid manufacturing to bring advanced therapies to market

whitePaper | December 13, 2022

The global demand for plasmid DNA has increased dramatically in recent years, fueled by a surge in the clinical development of next-generation cell and gene therapy products and more recently by the success of COVID-19 vaccines.

Read More

A REVIEW OF THE RESEARCH TRENDS AND DEVELOPMENTS

whitePaper | May 9, 2022

In the last decade, there has been an encouraging shift in research, clinical development, and commercial activity to exploit the many biological roles of ribonucleic acid (RNA) for use in medicine.

Read More

6 Strategies to Stimulate Patient Engagementin Rehab Therapy

whitePaper | August 25, 2022

Patient engagement has become a measure of healthcare analytics that many in rehab therapy have sought to quantify.

Read More

Accelerating the Biomanufacturing Revolution

whitePaper | February 11, 2022

The biomanufacturing revolution is here. Recent advancements in the field of synthetic biology have enabled significant cost reductions in foundational bioengineering unit operations such as DNA synthesis and sequencing.

Read More

bFGF Supports Human ES Cell Self-Renewal

whitePaper | March 24, 2023

Basic fibroblast growth factor (bFGF) is an important cytokine used to support the growth and self renewal of human embryonic stem cells.

Read More

Long-term follow-up studies of cell and gene therapies

whitePaper | September 29, 2022

The market is experiencing a surge in the availability of cell and gene therapies (CGTs); it’s estimated that by 2025 as many as 20 will be introduced into the US each year.1,2

Read More

Leveraging innovations in plasmid manufacturing to bring advanced therapies to market

whitePaper | December 13, 2022

The global demand for plasmid DNA has increased dramatically in recent years, fueled by a surge in the clinical development of next-generation cell and gene therapy products and more recently by the success of COVID-19 vaccines.

Read More

A REVIEW OF THE RESEARCH TRENDS AND DEVELOPMENTS

whitePaper | May 9, 2022

In the last decade, there has been an encouraging shift in research, clinical development, and commercial activity to exploit the many biological roles of ribonucleic acid (RNA) for use in medicine.

Read More

6 Strategies to Stimulate Patient Engagementin Rehab Therapy

whitePaper | August 25, 2022

Patient engagement has become a measure of healthcare analytics that many in rehab therapy have sought to quantify.

Read More

Accelerating the Biomanufacturing Revolution

whitePaper | February 11, 2022

The biomanufacturing revolution is here. Recent advancements in the field of synthetic biology have enabled significant cost reductions in foundational bioengineering unit operations such as DNA synthesis and sequencing.

Read More

bFGF Supports Human ES Cell Self-Renewal

whitePaper | March 24, 2023

Basic fibroblast growth factor (bFGF) is an important
cytokine used to support the growth and self renewal of
human embryonic stem cells.

Read More

Long-term follow-up studies of cell and gene therapies

whitePaper | September 29, 2022

The market is experiencing a surge in the availability
of cell and gene therapies (CGTs); it’s estimated that
by 2025 as many as 20 will be introduced into the US
each year.1,2

Read More

More Whitepapers

Spotlight

SE Healthcare

The SE Healthcare team has been at the forefront of enhancing safety and quality in healthcare for over 10 years. Our mission is to empower healthcare providers through the Physician Empowerment™ Suite, a set of specialty-specific data analytics platforms created to increase quality of care, reduce risk, improve reputation, and enhance reimbursements to enrich financial health.

Events

8th International Conference on Bio-Sensing Technology

Conference

8th International Conference on Bio-Sensing Technology

Conference